(MENAFN- Caribbean News International)
NEW YORK–(Small business WIRE)–On Thursday, June 16, 2022, far more than 900 men and women from above 100 companies from the leveraged finance and personal equity communities arrived together for the Leveraged Finance Fights Melanoma (LFFM) advantage and cocktail party. Hosted at the Museum of Fashionable Art, the occasion raised a report breaking $3 million for the Melanoma Exploration Alliance’s (MRA) mission to progress the world’s most progressive and promising melanoma research.
“Each 12 months, I carry on to be amazed by the community’s reaction to this celebration and the mission it supports,” says LFFM co-founder and MRA board member Jeff Rowbottom.“LFFM has come to be a signature celebration for the finance industry, and it plays a important function in advancing cancer study that is practically preserving lives, such as mine.”
LFFM funding supports chopping-edge melanoma exploration that has aided people with all sorts of cancer are living for a longer period, fuller life. Remedies initially pioneered in melanoma are now remaining made use of to address individuals with over 30 other cancer forms.
LFFM was established in 2011 by Jeff Rowbottom (Iron Park Capital) and Brendan Dillon (Veritas Capital) – the two melanoma survivors. Because its founding, LFFM has raised more than $19 million for MRA, the biggest nonprofit funder of melanoma analysis. Considering the fact that its founding in 2007, MRA-funded investigators have been deeply associated in each individual breakthrough in melanoma investigate, including the approval of 15 new therapies.
The party was co-chaired by Clare Bailhé (MidCap Fiscal), Brendan Dillon (Veritas Capital), Kerry Dolan (Brinley Companions), Lee Grinberg (Elliott Administration), Matt Manin (Apollo), George Mueller (KKR), Geoff Oltmans (Silver Lake), Kevin Pluff , Jeff Rowbottom (Iron Park Funds), Ian Schuman (Latham & Watkins), Cade Thompson (KKR), Trevor Watt (Hellman & Friedman), and Eric Wedel (Kirkland & Ellis).
Presenting sponsors of the party incorporated Latham & Watkins, Kirkland & Ellis, Simpson Thacher & Bartlett, Fitch Rankings, Michael Milken, HPS Investment Partners, Apollo|Midcap, Iron Park Capital Administration, Veritas Cash Management and White & Circumstance. A complete record of LFFM sponsors is incorporated beneath.
“The leveraged finance and non-public fairness communities are some of the biggest advocates for MRA and our mission to get rid of melanoma,” says MRA CEO Marc Hurlbert, PhD.“The money lifted from this celebration will even more accelerate the MRA exploration agenda and the continuation of more rapidly cures, new treatments and lifesaving breakthroughs.
LFFM 2022 Sponsors
Kirkland & Ellis
Latham & Watkins
Simpson Thacher & Bartlett LLP
HPS Investment decision Partners, LLC
Iron Park Cash
Veritas Cash Administration LLC
White & Circumstance LLP
Allen & Overy
BMO Cash Marketplaces
Davis Polk & Wardwell
Joyce and Barry Cohen
Shearman & Sterling LLP
Sidley Austin LLP
Bank of The us Merrill Lynch
Typical Atlantic Philanthropic Foundation
Hellman & Friedman
King & Spalding LLP
Leonard Environmentally friendly & Companions
Howard and Nancy Marks
New Mountain Finance Company
Ropes & Gray LLP
Sixth Street Companions
Skadden, Arps, Slate, Meagher & Flom LLP
T. Rowe Selling price
The Carlyle Team
Vista Fairness Associates
Weil, Gotshal & Manges LLP
Wells Fargo Financial institution
Royal Bank of Canada/RBC Cash Markets
American Industrial Partners
Ares Administration LLC
Blackstone Credit history
Blue Owl Money
Clayton, Dubilier & Rice LLC
Cleary Gottlieb Steen & Hamilton
Cravath, Swaine & Moore LLP
Debevoise & Plimpton
Deutsche Financial institution
Fried, Frank, Harris, Shriver & Jacobson LLP
Madison Dearborn Partners
Matt Nord and Erika Weinberg
Mizuho Securities United states of america, Inc.
MJX Asset Management LLC
Oak Hill Advisors, LP
Oak Hill Money Administration
Silver Rock Monetary
Stone Canyon Industries
Stone Issue Cash
Sullivan & Cromwell LLP
Wachtell, Lipton, Rosen & Katz
Winston & Strawn
Introduction Worldwide Corporation
Angelo Gordon & Co.
Brookfield Asset Administration
Funds Just one Bank
Clarion Capital Partners, LLC
GoldenTree Asset Administration, LP
Orchard Initial Source Asset Management
Paul Hastings LLP
Rothschild & Co.
Seix Expense Advisors
Shenkman Capital Management Inc.
Siris Money Group
Sumitomo Mitsui Banking Corporation (SMBC)
Warburg Pincus LLC
Z Funds Group
About Melanoma Exploration Alliance (MRA)
The Melanoma Investigation Alliance (MRA) stands as the premier non-earnings funder of melanoma analysis. Launched in 2007, MRA’s mission is to stop suffering and dying owing to melanoma by advancing the world’s most promising science and investigation. MRA presents significant funding for melanoma cancer investigate that propels improvements in prevention, prognosis, therapy, metastasis, and survivorship. MRA-funded researchers have been guiding every breakthrough in melanoma study. Because MRA’s inception, more than 15 new therapeutic techniques for melanoma have gained Food and drug administration approval. MRA is recognized as a person of the most fiscally productive non-revenue in the nation. For the reason that MRA’s Founders’ generously include 100% of MRA’s administrative and operating prices, each dollar donated is invested immediately into MRA’s scientific and investigate plan. For far more data, please check out: .
Cody R. Barnett, Director of Communications
M: (717) 880-7100
Additional Media Contacts:
Anreder & Firm
Steven S. Anreder —
Michael Wichman —
Legal Disclaimer: MENAFN gives the information and facts “as is” devoid of guarantee of any form. We do not settle for any duty or legal responsibility for the accuracy, information, images, movies, licenses, completeness, legality, or dependability of the info contained in this posting. If you have any problems or copyright concerns similar to this article, kindly contact the provider higher than.